England's NHS must offer transgender patients awaiting transitioning treatment access to fertility services, or face legal action according to the country's equality watchdog.
The UK’s national healthcare provider saved £324 million by switching its patients to “better value” biosimilar and generic drugs, which are considered to be “equally effective alternatives
Novelion Therapeutics’ Myalepta (metreleptin) developed for the ultra-rare condition lipodystrophy has been approved by the European Commission, giving patients the first treatment to impro
Another batch of vaccines have been found “substandard”, just days after the second-largest pharmaceutical company in China admitted to falsifying test results and producing hundreds of tho
Donald Trump may have convinced the US pharma giant Pfizer to defer a price increase for dozens of drugs, but there are others that have escaped such intense scrutiny according to a report.